5Normanno N, De Luca A, Bianco C, et al. Epidermal growth factor receptor( EGFR ) signaling in cancer [ J ]. Gene, 2006, 366( 1 ) :2 - 16.
6Akashi Y,Okamoto I,Iwasa T, et al. Enhancement of the antitumor activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non - small cell lung cancer cell lines of differing epidermal growth factor receptor status[ J ]. Br J Cancer,2008,98 (4) :749 -755.
7Nyati MK, Morgan MA, Feng FY, et al. Integration of EGFR inhibitors with radio - chemotherapy [ J ]. Nat Rev Cancer, 2006,6( 11 ) :876 - 885.
8Bentzen SM, Atasoy BM, Daley FM, et al. Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial[J]. J elin oncol,2005,23(24):5 560-5 567.
9Cohen EE, Rosen F, Stadler WM, et al. Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck[J]. J Clin Oncol,2003,21 (10): 1 980 - 1 987.
10Zhao K, Hu X, Wu X, et al. Phase 1 Trial of Escalating - Dose Nimotuzumab Given Weekly with Cisplatin, 5 -fluorouracil (5 -FU ) and Concurrent Radiotherapy in Locally Advanced Esophageal Carcinoma:An interim report [J]. I. J. Radiation Oncology Biology Physics,2010,78(3) :323 -324.
